ARTICLE | Financial News
Aimmune Therapeutics completes IPO
August 10, 2015 7:00 AM UTC
Aimmune Therapeutics Inc. (NASDAQ:AIMT), Brisbane, Calif. Business: Inflammation Date completed: 2015-08-06 Type: IPO Raised: $160 million Shares: 10 million Price: $16 Shares after offering: 40.7 mil...